Blockade of this interaction, either with nucleolin-binding pseudopeptide HB-19 or with anti-EF-Tu Ab, results in inhibition of LVS bacteria binding to human THP-1 cells and subsequent inhibition of bacterial infection. This evidence concerns the gene NUCLEOLIN and bacterial infectious disease.